USPTO serial 79276690
ITIND
Reviewed by CopyMark Law Group
Reg. 6087959Status 739Renewal
- Filing date
- Status date
- Registration date
- Jun 30, 2020
- Examiner
- COGAN, BRITTNEY LORRAINE
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ITIND?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $425
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Monica Riva Talley
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.1101 K Street, N.W.10th FloorWashingto, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical devices for the treatment of benign prostatic hyperplasia (BPH) and related prostatic disorders; medical devices for prostate, bladder and/or kidney related treatments, namely, urethral and transurethral stents, probes, obturators, temporary or permanent artificial implants, and catheters; medical apparatus for the non-surgical treatment of benign prostatic hyperplasia (BPH) and related prostatic disorders, comprised of stents, probes, obturators, temporary or permanent artificial implants, and catheters; catheter-type medical device for the therapeutic treatment of benign prostatic hyperplasia (BPH) and other urological disease states; medical devices for prostate tissue ablation or destruction, namely, urethral and transurethral stents, probes, obturators, temporary or permanent artificial implants, and catheters; medical devices for use in tissue ablation, and the treatment of prostate cancer, kidney or renal tumors, and benign prostatic hyperplasia (BPH); medical apparatus and instruments for treating urological conditions and diseases in humans, namely, a medical device that provides a port-like access to the kidneys, ureters, bladder, or urethra of patients to allow access and drainage of the urinary system; medical device, namely, a stent, temporary or permanent artificial implants, for placement in the urethra or prostate intended for removing prostate tissue through the urethra; medical devices, namely, stents, probes, obturators, temporary or permanent artificial implants, and catheters used to dilate strictured areas of the urethra | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 11, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Sep 11, 2026 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Sep 7, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 30, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jun 30, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 14, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 25, 2020 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 9, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 9, 2020 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Feb 18, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 17, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 17, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 28, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 24, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 23, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |